JACQUELINE HOSKINS: Open Payments
NPI 1316475171 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 15 payments from 11 companies in 2025. Trend: 2023 $695 · 2024 $1,171 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $226 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Globus Medical, Inc. | 1 | $117 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $110 |
| Medtronic, Inc. | 1 | $102 |
| MML US, Inc. | 1 | $48 |
| Valinor Pharma, LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
Products named: Ozempic, VOQUEZNA, AIRSUPRA, AUSTEDO XR, Senza, JOURNAVX, INTELLIS ADAPTIVESTIM, Wegovy.
Industry payments across FL — which companies pay providers there.
